In the case of prostate cancer, PEITC induces epigenetic modifications in vitro and in vivo by influencing the expression of genes related to inflammation-related TNFR signaling and PTEN/PI3K/AKT signaling [128]. Here, AKT1 is linked to prostate carcinoma.